Image

RFMN in Combination With 1927 nm Thulium Laser for Treating Photoaged Skin

Recruiting
30 years of age
Both
Phase N/A

Powered by AI

Overview

The appearance of the aging skin is influenced by different factors including by the reduced elasticity and increased laxity of the skin, the decreasing volume as well as pigmentation disorders and dilated vascular markings. Currently, there are different methods available to treat the aging skin. Here, the combined treatment of radiofrequency micro needling (RFMN) and thulium laser has been commonly used in clinical practice.

The aim of this clinical study is to investigate the efficacy, patient satisfaction, safety of RFMN and thulium laser treatment in patients with facial, age-related skin laxity, wrinkles, and pigmented lesions.

Eligibility

Inclusion Criteria:

  • Men and women from the age of 30 years
  • good general condition, no relevant previous diseases
  • Presence of wrinkles, dermatochalasis on the face, pigment spots, which are an indication for RFMN and thulium laser or comparable methods
  • Cognitive ability and willingness to give consent (informed consent)
  • Be willing and able to attend follow-up visits

Exclusion Criteria:

  • Age < 30 years
  • Pregnancy or breastfeeding
  • Excessive subcutaneous fatty tissue under the cheeks
  • Significant scarring of the region to be treated
  • open wounds or lesions of the region to be treated
  • Severe or cystic facial acne
  • Metallic implants in the face or neck region
  • Mental illnesses (psychoses, body perception disorders)
  • Use of isotretinoin or other retinoids, psychotropic drugs, coumarins or heparins in the last 2 weeks
  • Fillers in the region to be treated < 4 weeks prior and during the study period
  • Resurfacing (fractional, ablative, nonablative) of the region of interest < 2 months prior and during the study period
  • Plastic aesthetic procedures or other surgical procedures < 6 months prior and during the study period
  • Tendency to have excessive scarring
  • Lack of informed consent

Study details

Photoaging

NCT06029725

Universitätsklinikum Hamburg-Eppendorf

25 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.